Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 21:8:745906.
doi: 10.3389/fcvm.2021.745906. eCollection 2021.

Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs

Affiliations
Review

Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs

Addie B Spier et al. Front Cardiovasc Med. .

Abstract

Coronavirus disease 2019 (COVID-19) is the potentially lethal disease that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19 have an increased risk of thrombosis, but the role of thrombosis in the pathogenesis and progression of severe COVID-19 remains unclear. A better understanding of the contribution of thrombosis to the development and progression of COVID-19 could lead to the development of novel COVID-19 treatments. For this reason, established and emerging histological techniques have recently been used to analyze COVID-19 lungs quantitatively and visually and in two and three dimensions. The gold standard and novel state-of the-art histological techniques that have been used to assess thrombosis in COVID-19 lungs are described in this Mini Review.

Keywords: COVID - 19; histology; lung; pulmonary; thrombosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

  • Editorial: Highlights in Thrombosis: 2021.
    Evans CE. Evans CE. Front Cardiovasc Med. 2022 Feb 24;9:863030. doi: 10.3389/fcvm.2022.863030. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35282334 Free PMC article. No abstract available.

References

    1. Page EM, Ariëns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res. (2021) 200:1–8. 10.1016/j.thromres.2021.01.005 - DOI - PMC - PubMed
    1. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, et al. . Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. (2020) 18:1995–2002. 10.1111/jth.14888 - DOI - PMC - PubMed
    1. Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. . COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. (2020) 120:998–1000. 10.1055/s-0040-1714350 - DOI - PMC - PubMed
    1. Xu B, Gutierrez B, Mekaru S, Sewalk K, Goodwin L, Loskill A, et al. . Epidemiological data from the COVID-19 outbreak, real-time case information. Sci Data. (2020) 7:106. 10.1038/s41597-020-0448-0 - DOI - PMC - PubMed
    1. Iacus SM, Natale F, Santamaria C, Spyratos S, Vespe M. Estimating and projecting air passenger traffic during the COVID-19 Coronavirus outbreak and its socio-economic impact. Saf Sci. (2020) 129:104791. 10.1016/j.ssci.2020.104791 - DOI - PMC - PubMed